I heard a justification of all this at the EGM by phil daffis, made me confident of their plan, and with a guy who was VP of marketing at Cochlear I reckon he knows more than I do...don't forget they have noted a milestone of a commercial product in the dementia industry back end of 2017. Revenue is thus expected, they have clearly stated the milestones they aim to achieve for commercialisation, I read an annual report of another company this week which was scarce on timing for their commercial product. I think a point will come where the market will click that EPT isn't that far away from being commercial with a product .
- Forums
- ASX - By Stock
- MNQ
- Ann: Change of Company Name-MNQ.AX
Ann: Change of Company Name-MNQ.AX, page-34
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online